Experimental Anti-Aging Treatment That Kills Old Cells Has Passed First Human Trial

Experimental Anti-Aging Treatment That Kills Old Cells Has Passed First Human Trial

-Not all damaged cells die. Some stick around as senescent cells, unable to divide but still able to produce chemical signals — and they could play a major role in the battle against aging.

-Results of a trial in which scientists treated 14 patients suffering from the fatal lung condition idiopathic pulmonary fibrosis (IPF) with a drug combination they believed would clear out senescent cells.

-Over the course of three weeks, patients took nine doses of a leukemia drug called dasatinib and quercetin, a supplement.

-By the end of the trial, the patients were reportedly able to walk farther than they could previously in the same amount of time and other signs of improved well being — all without any serious side effects.